Descemet’s membrane endothelial keratoplasty

Descemet’s membrane endothelial keratoplasty
Colin Kerr
Colin Kerr
Published: Wednesday, July 6, 2016
moria-image-1GRAFT PREPARATION Moria has announced an extension in its portfolio for Descemet’s membrane endothelial keratoplasty (DMEK) graft preparation. “In addition to Muraine Punch introduced in 2013 to allow the reverse technique by Prof Muraine (Rouen, France), Moria now releases new Single-Use Donor Vacuum Guarded Punches to safely assist corneal surgeons and/or eye bank practitioners in the preparation of purely endothelial DMEK graft following the SCUBA (“no touch”) technique: the Guarded DMEK Punch (SKU 17207Dxxx),” said a company spokesman. “Its 350-micron guarded blade is designed to make a non-penetrating trephination of the Descemet’s membrane all around 360° without any hinge, so delamination becomes an easy process,” he added. www.moria-surgical.com REVENUE INCREASE Carl Zeiss Meditec AG has announced that it has increased its revenue by 8.6 per cent in the first six months of the fiscal year, to €540.8 million. “The encouraging development of business confirms our strategy. We optimise the clinical benefit of our products without losing sight of the economic aspects of our customers,” said Dr Ludwin Monz, president and CEO of Carl Zeiss Meditec AG. www.zeiss.com/med CE MARK OASIS® Medical has obtained a CE Mark opening the doors to the international market for their SOFT SHIELD® Collagen Corneal Shields, which allow for ocular healing to take place by providing a protective barrier over the surface of the eye. “As the shield gradually degrades, a thin layer of collagen is released which helps lubricate the eye,” said a company spokeswoman. “SOFT SHIELD® Collagen Corneal Shields are clear, pliable, thin film of highly purified bovine collagen that has been lightly crosslinked to provide the desired degradation time on the eye,” added the spokeswoman. www.oasismedical.com
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...